The β-adrenergic receptors

Herz

Volumn 27, Issue 7, 2002, Pages 683-690

  Wallukat, Gerd ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

adrenoceptor; Desensitisation; Dilatative cardiomyopathy; Embryonic stem cells; Overexpression

Indexed keywords

ADENYLATE CYCLASE; AUTOANTIBODY; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; CATECHOLAMINE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; G PROTEIN COUPLED RECEPTOR KINASE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; RECEPTOR ANTIBODY; RNA; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; CARBOXY TERMINAL SEQUENCE; CATECHOLAMINE RELEASE; CYTOSOL; HEART FAILURE; INTERNALIZATION; MORTALITY; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; RECEPTOR INTRINSIC ACTIVITY; REVIEW; SECOND MESSENGER; SIGNAL TRANSDUCTION;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ANIMALS, NEWBORN; ARRHYTHMIA; AUTOANTIBODIES; CALCIUM; CARDIOMYOPATHY, DILATED; CELL DIFFERENTIATION; CELLS, CULTURED; DOWN-REGULATION; EMBRYO; HEART FAILURE, CONGESTIVE; HOMEOSTASIS; HUMANS; IMMUNOGLOBULIN G; MICE; MICE, TRANSGENIC; MYOCYTES, CARDIAC; PHOSPHORYLATION; PROPRANOLOL; RATS; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, ADRENERGIC, BETA-1; RNA, MESSENGER; SARCOLEMMA; SIGNAL TRANSDUCTION; STEM CELLS; STROKE VOLUME;

EID: 0036859163     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-002-2434-z     Document Type: Review

References (60)

1. Ahlquist RP. A study of the adrenotropic receptors. Am J Physiol 1948;153:586-600.
2. Lands AM, Arnold A, McAuliff JB, Luduena AP, Brown TG. Differentiation of receptor system activated by sympaticomimetic amines. Nature 1967;214:597-8.
3. Ablad B, Carlsson B, Dahlöf C, Ek L, Hultberg E. Cardiac effects of β-adrenergic receptor antagonists. Adv Cardiol 1974;12:290-302.
4. Bylund DB, Eikenberg DC, Hieble JP, Langer SZ, Lefkowitz RJ, Minneman KP, Molinoff PB, Ruffolo RR, Trendelenburg U. IV. International Union of Pharmacology Nomenclature of Adrenoceptors. Pharmacol Rev 1994;46:121-36.
5. Kaumann AJ, Molenaar P. Modulation of human cardiac function through 4 β-adrenoceptor population. Naunyn-Schmiedeberg's Arch Pharmacol 1997;355:667-8.
6. Brodde OE. β1- and β2-adrenoceptors in the human heart: Properties, function, and alterations in chronic heart failure, Pharmacol Rev 1991;43:203-42.
7. Mc Devitt DG. In vivo studies on the function of cardiac βadrenoceptors in man. Eur Heart J 1989;10:Suppl B:22-8.
8. Brodde OE, Michel MC. Adrenergic and muscarinic receptors in the human heart. Pharmacol Rev 1999;51:651-90.
9. Strader CD, Candelore MR, Hill WS, Dixon RAF, Sigal IS. Identification of two serine residues involved in agonistic activation of the β-adrenergic receptor. J Biol Chem 1989;264:13572-8.
10. Strosberg AD. Structure, function and regulation of adrenergic receptors. Prot Sci 1993;2:1198-209.
11. Liggett S. Functional properties of human β2-adrenergic receptor polymorphisms. NIPS 1995;10:265-73.
12. Dixon RAF, Sigal I, Candelore MR, Rogister RB, Scattergood W, Rands E, Strader CD. Structural features required for ligand bindingto the β-adrenergic receptor. EMBO J 1987;6:3269-75.
13. Dohlman HG, Caron MG, de Blasi A, Frielle T, Lefkowitz RJ. Role of extracellular disufide-bonded cysteines in the ligand binding function of the β2-adrenergic receptor. Biochemistry 1990;29:2335-42.
14. Wallukat G, Wollenberger A, Morwinski R, Pitschner HF. Anti-β1-adrenoceptor autoantibodies with chronotropic activity from the serum of patients with dilated cardiomyopathy: Mapping of epitopes on the first and second extracellular loops. J Mol Cell Cardiol 1995;27:397-406.
15. Benovic JL, Pike LJ, Cerione RA, Staniszewski C, Yoshimasa T, Codina J, Caron MG, Lefkowitz RJ. Phosphorylation of the mammalian β-adrenergic receptor by cyclic AMP-dependent protein-kinase. J Biol Chem 1985;260:7094-101.
16. Hoebeke J. Structural basis of autoimmunity against G protein coupled membrane receptors. Int J Cardiol 1996;54:103-11.
17. Lefkowitz RJ. G protein-coupled receptors. III. New roles for receptor kinases and β-arrestines in receptor signaling and desensitization. J Biol Chem 1998;273:18677-80.
18. Rapacciuolo A, Rockman HA. Role of β-adrenoceptor desensitisation in heart failure. Cardiovasc Drug Rev 2000;17:384-94.
19. Koch WJ, Rockman HA, Samana P, et al. Cardiac function in mice overexpressing the β-adrenergic receptor kinase or a β-ARK inhibitor. Science 1995;268:1350-3.
20. Kallal L, Gagnon AW, Penn RP, Benovic JL. Visualization of agonist-induced sequestration and down-regulation of a green fluorescent protein-tagged beta2-adrenergic receptor. J Biol Chem 1998;273:322-8.
21. Lohse MJ, Benovic JL, Caron MG, Lefkowitz RJ. Multiple pathways of rapid β2-adrenergic receptor desensitisation: Delineation with specific inhibitors. J Biol Chem 1990;265:3202-9.
22. Ruiz-Gomez A, Mayor F. β-adrenergic receptor kinase (GRK2) colocalized with β-adrenergic receptors during agonist-induced receptor internalisation. J Biol Chem 1997;272:9601-4.
23. Mills SE. Implication of feedback regulation of beta-adrenergic signaling. J Anim Sci 2002;80:E30-5.
24. Hadcock JR, Ros M, Malbon CC. Agonist regulation of β-adrenergic receptor mRNA. Analysis in S49 mouse lymphoma mutants. J Biol Chem 1989;264:13956-61.
25. Guest SJ, Hadcock JR, Watkins DC, Malbon CC. β1-and β2-adrenergic receptor expression in differentiating 3T3-Li cells. J Biol Chem 1990;265:5370-5.
26. Port JD, Huang LY, Malbon CC. β-adrenergic agonists that downregulate receptor mRNA up-regulate a Mr 35,000 protein(s) that selectively binds to β-adrenergic receptor mRNA. J Biol Chem 1992;267:24103-8.
27. Podlowski S, Luther HP, Morwinski R, Müller J, Wallukat G. Agonistic anti-β1-adrenergic receptor autoantibodies from cardiomyopathy patients reduce the β1-adrenergic receptor expression in neonatal rat cardiomyocytes. Circulation 1998;98:2470-6.
28. Wallukat G, Wobus AM. Use of spontaneously beating heart muscle cells differentiating from pluripotental embryonic stem cells for testing of chronotropic agents. Arch Toxicol 1991;14:136-8.
29. 2+ channel blockers. Differentiation 1991;48:173-82.
30. Kehat I, Kenyagin-Karsenti D, Snir M, Segev H, Amit M, Gepstein A, Livne E, Binah O, Itskovitz-Eldor J, Gepstein L. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 2001;108:407-14.
31. Thomas JA, Marx BH. Plasma norepinephrine in congestive heart failure. Am J Cardiol 1978;41:233-43.
32. Leimbach WN, Wallin BG, Victor RG, Aylward PE, Sudhoef G, Mark AL. Direct evidence from intraneuronal recordings for increased central sympathetic outflow in patients with heart failure. Circulation 1986;73:913-9.
33. Bristow MR, Ginsburg R, Umans V, Fowler MB, Minobe WA, Rassmussen R, Zera P, Melove R, Shah P, Jamieson S, Stinson EB. β1- and β2-adrenergic receptor-subtypes in non-failing and failing ventricular myocardium: Coupling of both receptor subtypes to muscle contraction and selective β1-receptor down-regulation in heart failure. Circ Res 1986;59:297-309.
34. Haft J. Cardiovascular injury induced by sympathetic catecholamines. Prog Cardiovasc Dis 1974;17:73-86.
35. Ungerer M, Böhm M, Elce JS, Erdmann E, Lohse MJ. Altered expression of β-adrenergic receptor kinase and β1-adrenergic receptors in the failing human heart. Circulation 1993;87:454-63.
36. Bristow MR, Minobe W, Rasmussen R, Hershberger RE, Hoffman BB. Reduced β1-receptor messenger RNA abundance in the failing human heart. J Clin Invest 1993;92:2737-45.
37. Böhm M, Gierschik P, Jacobs KH, Pieske B, Schnabel P, Ungerer M, Erdmann E. Increase in Giα in human hearts with dilated but not ischemic cardiomyopathy. Circulation 1990;82:1249-65.
38. Böhm M. Alteration of β-adrenoceptor-G protein-regulated adenylyl cyclase in heart failure. Mol Cell Biochem 1995;147:147-60.
39. Maisch B, Deeg P, Liebau G, Kochsiek K. Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy. Am J Cardiol 1983;52:1072-8.
40. Fu LXM, Magnusson Y, Bergh CH, Waagstein F, Hjalmarson Å, Hoebeke J. Localization of a functional autoimmune epitope on the second extracellular loop of the human muscarinic receptor in patients with idiopathic dilated cardiomyopathy. J Clin Invest 1993;91:1964-8.
41. Wallukat G, Wollenberger A. Effect o gamma globulin fraction of patients with allergic asthma and dilated cardiomyopathy on chronotropic β-adrenoceptor function in cultured neonatal rat heart myocytes. Biomed Biochem Acta 1987;46:634-9.
42. Limas CJ, Goldenberg IF, Limas C. Autoantibodies against β-adrenoceptors in human dilated cardiomyopathy. Circ Res 1989;64:97-103.
43. Magnusson Y, Wallukat G, Waagstein F, Hjalmarson Å, Hoebeke J. Autoimmunity in idiopathic dilated cardiomyopathy - Characterization of antibodies against the β1-adrenoceptor with positive chronotropic effect. Circulation 1994;89:2760-7.
44. Jahns R, Boivin V, Siegmund C, Inselmann G, Lohse MJ, Boege F. Autoantibodies activating human β1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure. Circulation 1999;99:649-54.
45. Wallukat G, Kayser A, Wollenberger A.: The β1-adrenoceptor as antigen: Functional aspects. Eur Heart J 1995;16:85-8.
46. Jahns R, Boivin V, Krapf T, Wallukat G, Boege F, Lohse MJ. Modulation of beta1-adrenoceptor activity by domain-specific antibodies and heart failure-associated autoantibodies. J Am Coll Cardiol 2000;36:1280-7.
47. Krause EG, Bartel S, Beyerdörfer I, Wallukat G. Activation of cyclic AMP-dependent protein kinase in cardiomyocytes by anti-β1-adrenoceptor autoantibodies from patients with idiopatic dilated cardiomyopathy. Blood Press 1996;5:37-40.
48. Mijares A, Lebesgue D, Argibay J, Hoebeke J. Anti-peptide antibodies sensitive to the active state of the β2-adrenergic receptor. FEBS Lett 1996;399:188-91.
49. Lebesgue D, Wallukat G, Mijares A, Granier C, Argibay J, Hoebeke J. An agonist-like monoclonal antibody against the human β2-adrenoceptor. Eur J Pharmacol 1998;348:123-33.
50. Elies R, Fu LXM, Eftekhari P, Wallukat G, Schulze W, Granier C, Hjalmarson Å, Hoebeke J. Immunochemical and functional characterization of an agonist-like monoclonal antibody against the M2 acetylcholine receptor. Eur J Biochem 1998;251:659-66.
51. Francis GS, Goldsmith SR, Olivari MT, Levin TB, Cohn JN. The neuronal humoral axis in congestive heart failure. Ann Intern Med 1984;101:370-7.
52. Christ T, Wettwer E, Dobrev D, Adolph E, Knaut M, Wallukat G, Ravens U. Autoantibodies against the β1-adrenoceptor from patients with dilated cardiomyopathy prolong action potential duration and enhance contractility in isolated cardiomyocytes. J Mol Cell Cardiol 2001;33:515-25.
53. Engelhardt S, Boknik P, Keller U, Neumann J, Lohse MJ, Hein L. Early impairment of calcium handling and altered expression of junctin in hearts of mice overexpressing the β1-adrenergic receptor. FASEB J 2001;15:2718-20.
54. Beukelmann DJ, Näbauer M, Erdmann E. Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circulation 1992;85:1046-55.
55. Engelhardt S, Hein L, Wiesmann F, Lohse MJ. Progressive hypertrophy and heart failure in β1-adrenergic receptor transgenic mice. Proc Nat Acad Sci USA 1999;96:7059-64.
56. Vatner SF, Vatner DE, Homcy CJ. Beta-adrenergic receptor signalling: An acute compensatory adjustment-inappropriate for the chronic stress of heart failure? Insights from Gsalpha overexpression and other genetically engineered animal models. Circ Res 2000;86:502-6.
57. Geng YJ, Ishikawa Y, Vatner DE, Wagner TE, Bishop SP, Vatner SF, Homcy CJ. Apoptosis of cardiac myocytes in Gsalpha transgenic mice. Circ Res 1999;84:34-42.
58. Asai K, Yang GP, Geng YJ, Takagi G, Bishop S, Ishikawa Y, Shannon RP, Wagner TE,Vatner DE, Homcy CJ, Vatner SF. Beta-adrenergic receptor blockade arrest myocyte damage and preserves cardiac function in transgenic Gs(alpha) mouse. J Clin Invest 1999;104:551-8.
59. Antos CL, Frey N, Marx SO, Reiken S, Garburjakova M, Richardson JA, Marks AR, Olson EN. Dilated cardiomyopathy and sudden death resulting from constitutive activation of protein kinase A. Circ Res 2001;89:997-1004.
60. Lohse MJ, Engelhardt S. Protein kinase A transgenes. The many faces of cAMP. Circ Res 2001;89:938-40.